Literature DB >> 3536531

Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.

E van Ganse, J Douchamps, F Deger, M Staroukine, A Verniory, A Herchuelz.   

Abstract

The effects of torasemide, a new potent loop diuretic, on renin release, water and sodium excretion were investigated in young healthy volunteers before and after 3 days of treatment with indomethacin. Torasemide 20 mg i.v. induced a rapid and biphasic increase both in plasma renin activity and plasma angiotensin II levels, which was almost completely abolished by pretreatment with indomethacin. Torasemide also increased urine volume, sodium excretion and, during the first hour after dosing, the creatinine clearance. None of the latter effects was impaired by indomethacin pretreatment. It is concluded that, like other loop diuretics, torasemide stimulates renin release by increasing renal prostaglandin production. However, at variance with what is observed with other loop diuretics, the diuretic and natriuretic effects of torasemide as well as the change in creatinine clearance do not appear to be inhibited by indomethacin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536531     DOI: 10.1007/BF00541466

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  Adrenergic receptor mediation of renin secretion.

Authors:  N Winer; D S Chokshi; M S Yoon; A D Freedman
Journal:  J Clin Endocrinol Metab       Date:  1969-09       Impact factor: 5.958

2.  Inhibition of ethacrynic acid induced increase in renal blood flow by indomethacin.

Authors:  H E Williamson; W A Bourland; G R Marchand
Journal:  Prostaglandins       Date:  1974-11-25

3.  Measurement of concentrations of angiotensin I in human blood by radioimmunoassay.

Authors:  M A Waite
Journal:  Clin Sci       Date:  1973-07       Impact factor: 6.124

4.  Indomethacin-furosemide interaction: the importance of renal blood flow.

Authors:  A S Nies; J Gal; S Fadul; J G Gerber
Journal:  J Pharmacol Exp Ther       Date:  1983-07       Impact factor: 4.030

5.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

6.  Attenuation of furosemide's diuretic effect by indomethacin: pharmacokinetic evaluation.

Authors:  D E Smith; D C Brater; E T Lin; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

7.  Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man.

Authors:  P Chennavasin; R Seiwell; D C Brater
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

8.  The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.

Authors:  J L Data; A Rane; J Gerkens; G R Wilkinson; A S Nies; R A Branch
Journal:  J Pharmacol Exp Ther       Date:  1978-08       Impact factor: 4.030

9.  Role of prostaglandins in the hemodynamic and tubular effects of furosemide.

Authors:  J G Gerber
Journal:  Fed Proc       Date:  1983-04

10.  Pharmacological properties of the new potent diuretic torasemide in rats and dogs.

Authors:  A Ghys; J Denef; J M de Suray; M Gerin; A Georges; J Delarge; J Willems
Journal:  Arzneimittelforschung       Date:  1985
View more
  3 in total

Review 1.  Torasemide. A review of its pharmacological properties and therapeutic potential.

Authors:  H A Friedel; M M Buckley
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 2.  Torasemide. An update of its pharmacological properties and therapeutic efficacy.

Authors:  C J Dunn; A Fitton; R N Brogden
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 3.  Benefits and risks of torasemide in congestive heart failure and essential hypertension.

Authors:  D C Brater
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.